We are a
Life Sciences Company that Cares
We are transforming the drug discovery and development process and accelerating the creation of life-changing psilocybin drugs on behalf of patients.
CSE: MYND / OTC: MYNDF
We strongly believe in supporting people suffering from neuroinflammatory diseases and we believe our research can help change lives
Mynd was founded by Dr. Wilfred Jefferies and Dr. Lyle Oberg with the goal of improving mental health. Dr. Jefferies is a world-renowned Neuroimmunologist with over 60 patents and 100 publications in prestigious medical journals, including Nature and The Lancet.
Through Dr. Jefferies research conducted over the past 30 years and the executive leadership of
Dr. Oberg, we intend to establish the link between depression and inflammation in the brain and ultimately develop a pharmaceutical treatment utilizing compounds found in Psilocybin.
Strength in Leadership
Dr. Lyle Oberg
CO-FOUNDER & CEO
Dr. Wilfred Jeffries
CO-FOUNDER &
CHIEF SCIENCE OFFICER
Luke Warkentin
VP CORPORATE DEVELOPMENT
Lih-Ming Tam
SENIOR CONTROLLER
Dr. Chaahat SB Singh
OPERATIONS &
RESEARCH MANAGER
Dr. Iryna Saranchova
CHIEF CLINICAL OFFICER
Board of Directors
Dr. Wilfred Jefferies
Board Chair
Dr. Lyle Oberg
Director
Roslyn Ritchie-Derrien
Director
Scott Nicoll
Director
Audit Committee Chair
Jay Campbell
Director
Compensation Committee Chair
Scientific Advisory Board
Mark A Geyer, PhD
University of California San Diego
Dr. John Trowsdale
University of Cambridge
Dr. Michael Brownstein
University of Chicago
